SEC Comment Letter 0000000000-24-012223 to CEL SCI CORP (CVM)
CEL SCI CORP
Date: Nov. 4, 2024 · CIK: 0000725363 · Accession: 0000000000-24-012223
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282844
Letter
November 4, 2024 Geert Kersten Chief Executive Officer CEL-SCI Corporation 8229 Boone Blvd. #802 Vienna, Virginia 22182 Re:CEL-SCI Corporation Registration Statement on Form S-3 Filed October 25, 2024 File No. 333-282844 Dear Geert Kersten: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:William Hart, Esq.
Show Raw Text
November 4, 2024
Geert Kersten
Chief Executive Officer
CEL-SCI Corporation
8229 Boone Blvd. #802
Vienna, Virginia 22182
Re:CEL-SCI Corporation
Registration Statement on Form S-3
Filed October 25, 2024
File No. 333-282844
Dear Geert Kersten:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:William Hart, Esq.